ELVN Insider Transactions
740 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ELVN insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-08-17 | Sale | 1,388 | $59.3536 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-08-17 | Sale | 4,630 | $58.3517 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-08-17 | Sale | 1,100 | $59.3465 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-08-17 | Sale | 3,900 | $58.3717 |
|---|
| Derynck Mika K | Director | 2026-08-04 | Sale | 158,795 | $60.2134 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-07-17 | Sale | 123 | $53.8716 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-07-17 | Sale | 2,638 | $53.3825 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-07-17 | Sale | 2,564 | $52.318 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-07-17 | Sale | 369 | $51.4823 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-07-17 | Sale | 324 | $49.9715 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-07-17 | Sale | 63 | $53.9208 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-07-17 | Sale | 2,184 | $53.4199 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-07-17 | Sale | 2,063 | $52.3921 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-07-17 | Sale | 459 | $51.5466 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-07-17 | Sale | 231 | $50.0542 |
|---|
| Kunkel Lori Anne | Director | 2026-07-06 | Sale | 5,889 | $50.8442 |
|---|
| Kunkel Lori Anne | Director | 2026-07-06 | Sale | 4,111 | $49.9834 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-22 | Sale | 46,776.0 | $45.0 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-22 | Sale | 46,776.0 | $45.0 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-22 | Sale | 46,776.0 | $45.0 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-22 | Sale | 787,024.0 | $45.38 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-22 | Sale | 787,024.0 | $45.38 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-22 | Sale | 787,024.0 | $45.38 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-22 | Sale | 1,477.0 | $45.0 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-22 | Sale | 1,477.0 | $45.0 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-22 | Sale | 1,477.0 | $45.0 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-22 | Sale | 24,846.0 | $45.38 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-22 | Sale | 24,846.0 | $45.38 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-22 | Sale | 24,846.0 | $45.38 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-06-17 | Sale | 1,238.0 | $44.75 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-06-17 | Sale | 3,401.0 | $43.86 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-06-17 | Sale | 1,379.0 | $42.79 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-06-17 | Sale | 1,133.0 | $44.74 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-06-17 | Sale | 2,599.0 | $43.87 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-06-17 | Sale | 1,268.0 | $42.83 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-15 | Sale | 272,322.0 | $45.02 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-15 | Sale | 272,322.0 | $45.02 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-15 | Sale | 272,322.0 | $45.02 |
|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2026-06-15 | Sale | 9,086.0 | $45.02 |
|---|
| OrbiMed Capital GP VII LLC | TenPercentOwner | 2026-06-15 | Sale | 9,086.0 | $45.02 |
|---|
| OrbiMed Genesis GP LLC | TenPercentOwner | 2026-06-15 | Sale | 9,086.0 | $45.02 |
|---|
| Kunkel Lori Anne | Director | 2026-06-05 | Sale | 354.0 | $35.82 |
|---|
| Kunkel Lori Anne | Director | 2026-06-05 | Sale | 1,867.0 | $35.36 |
|---|
| Kunkel Lori Anne | Director | 2026-06-05 | Sale | 7,779.0 | $34.28 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-05-18 | Sale | 223.0 | $41.21 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-05-18 | Sale | 1,302.0 | $40.25 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-05-18 | Sale | 3,475.0 | $39.53 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-04-17 | Sale | 2,441.0 | $48.06 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-04-17 | Sale | 2,419.0 | $47.39 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-04-17 | Sale | 140.0 | $45.81 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-03-25 | Sale | 40,000.0 | $35.1 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-03-17 | Sale | 5,000.0 | $27.76 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-03-10 | Sale | 10,129.0 | $30.19 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-03-09 | Sale | 29,871.0 | $30.02 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2026-03-06 | Sale | 10,000.0 | $29.58 |
|---|
| Collins Helen Louise | CHIEF MEDICAL OFFICER | 2026-02-17 | Sale | 45,000.0 | $26.17 |
|---|
| Heyman Richard A. | Director | 2026-02-17 | Sale | 1,230.0 | $26.18 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-02-06 | Sale | 5,000.0 | $29.04 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-20 | Sale | 14,509.0 | $26.9 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-20 | Sale | 5,491.0 | $26.37 |
|---|
| Heyman Richard A. | Director | 2026-01-20 | Sale | 718.0 | $26.96 |
|---|
| Heyman Richard A. | Director | 2026-01-20 | Sale | 512.0 | $26.46 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2026-01-09 | Sale | 243.0 | $28.5 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2026-01-09 | Sale | 48,057.0 | $27.98 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-09 | Sale | 50,000.0 | $29.13 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-09 | Sale | 41,198.0 | $24.9 |
|---|
| Heyman Richard A. | Director | 2026-01-09 | Sale | 4,285.0 | $25.0 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-08 | Sale | 33,802.0 | $24.92 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2026-01-08 | Sale | 7,500.0 | $20.13 |
|---|
| Heyman Richard A. | Director | 2026-01-08 | Sale | 8,015.0 | $25.04 |
|---|
| Heyman Richard A. | Director | 2026-01-08 | Sale | 1,620.0 | $25.0 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-12-19 | Sale | 5,000.0 | $16.84 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-12-08 | Sale | 1,705.0 | $21.78 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-12-08 | Sale | 4,958.0 | $20.76 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-11-19 | Sale | 492.0 | $23.09 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-11-19 | Sale | 12,008.0 | $22.3 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-11-17 | Sale | 12,500.0 | $21.82 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-11-07 | Sale | 613.0 | $17.94 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-11-07 | Sale | 6,054.0 | $17.35 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-10-20 | Sale | 12,500.0 | $22.08 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-10-17 | Sale | 12,500.0 | $21.33 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-10-07 | Sale | 6,667.0 | $20.1 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2025-09-29 | Sale | 3,250.0 | $20.4 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-09-26 | Sale | 3,700.0 | $20.06 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-09-26 | Sale | 4,000.0 | $20.25 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-09-23 | Sale | 2,800.0 | $20.03 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-09-23 | Sale | 1,500.0 | $20.03 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-09-19 | Sale | 2,130.0 | $20.02 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-09-19 | Sale | 4,870.0 | $19.11 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-09-19 | Sale | 1,000.0 | $20.25 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-09-17 | Sale | 5,000.0 | $19.09 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-09-08 | Sale | 6,667.0 | $20.24 |
|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | 2025-08-27 | Sale | 3,250.0 | $20.63 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-08-21 | Sale | 7,500.0 | $20.01 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-08-20 | Sale | 1,517.0 | $20.0 |
|---|
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | 2025-08-19 | Sale | 5,000.0 | $19.62 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-08-19 | Sale | 590.0 | $20.0 |
|---|
| Kintz Samuel | PRESIDENT AND CEO | 2025-08-18 | Sale | 10,393.0 | $20.02 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-08-07 | Sale | 405.0 | $18.93 |
|---|
| Patel Anish | CHIEF OPERATING OFFICER | 2025-08-07 | Sale | 6,262.0 | $18.2 |
|---|